InvestorsHub Logo
Followers 26
Posts 1574
Boards Moderated 0
Alias Born 03/01/2012

Re: None

Thursday, 07/28/2016 12:51:45 PM

Thursday, July 28, 2016 12:51:45 PM

Post# of 116986
Pump and dump through and through...

"Protagenic Therapeutics, Inc., formerly Atrinsic, Inc., is a biotechnology company. The Company is focused on the discovery, research and development of pre-clinical studies for developing naturally occurring, human neuropeptide-based, brain-active therapeutics for treatment of depression, mood, anxiety and other neurodegenerative disorders. The Company focuses on acquiring intellectual property rights for peptide-based therapeutics for the treatment of neurological and mood disorders. The Company focuses on advancing PT00114 through Investigational New Drug (IND)-enabling studies, and entering PT00114 into clinical proof-of-concept studies in treatment-resistant depression (TRD) and/or post-traumatic stress disorder (PTSD). PT00114 is a synthetic form of the natural peptide sequence Teneurin C-Terminal Associated Peptide (TCAP)-1. The Company's subsidiary includes Atrinsic, Inc. The Company has not generated any revenue."

From Google finance

https://www.google.com/finance?q=OTCMKTS%3AATRND&ei=YzeaV-mALMb-iAL_uYzIDA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PTIX News